coronaviru
cov
infect
commonli
associ
respiratori
enter
diseas
human
anim
outbreak
sever
acut
respiratori
syndrom
sar
highlight
potenti
lethal
consequ
covinduc
diseas
human
novel
cov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
caus
human
case
thu
far
fatal
outcom
studi
character
merscov
replic
cytotox
human
monkey
cell
line
electron
microscopi
infect
vero
cell
reveal
extens
membran
rearrang
includ
format
doublemembran
vesicl
convolut
membran
implic
previous
rna
synthesi
sarscov
cov
follow
infect
observ
rapidli
increas
viral
rna
synthesi
releas
high
titr
infecti
progeni
follow
pronounc
cytopatholog
characterist
use
develop
assay
antivir
compound
screen
format
use
identifi
cyclosporin
inhibitor
merscov
replic
cell
cultur
furthermor
merscov
found
time
sensit
alpha
interferon
ifna
treatment
sarscov
observ
may
import
implic
treatment
merscovinfect
patient
merscov
infect
prevent
ifninduc
nuclear
transloc
phosphoryl
contrast
infect
sarscov
block
inhibit
express
antivir
gene
find
highlight
relev
differ
distantli
relat
zoonot
cov
term
interact
evas
cellular
innat
immun
respons
june
previous
unknown
coronaviru
isol
saudi
arabian
patient
die
acut
respiratori
distress
syndrom
multipl
organ
failur
subsequ
novel
viru
isol
sever
addit
resid
visitor
arabian
peninsula
suffer
similar
respiratori
symptom
retrospect
cluster
respiratori
infect
jordan
april
link
agent
although
convinc
evid
humantohuman
transmiss
obtain
clearli
differ
cluster
three
uk
case
earli
consist
patient
travel
saudi
arabia
two
famili
member
without
recent
travel
histori
outsid
uk
past
procknow
mcintosh
et
al
outbreak
sever
acut
respiratori
syndrom
sar
fatal
reveal
potenti
lethal
consequ
covinduc
diseas
human
drosten
et
al
ksiazek
et
al
two
year
later
bat
identifi
like
anim
reservoir
zoonot
cov
li
et
al
subsequ
wide
varieti
batassoci
cov
discov
vijaykrishna
et
al
woo
et
al
two
addit
human
cov
fouchier
et
al
van
der
hoek
et
al
woo
et
al
also
identifi
although
gener
capac
bat
cov
switch
host
appear
rather
restrict
et
al
possibl
sarscov
reemerg
zoonot
transfer
anim
cov
remain
public
health
concern
past
year
cov
classifi
four
genera
alpha
beta
gammaand
deltacoronavirus
de
groot
et
al
previou
analysi
merscov
genom
identifi
newli
emerg
agent
member
lineag
c
genu
betacoronaviru
strikingli
case
sarscov
closest
known
rel
merscov
bat
coronavirus
van
boheemen
et
al
woo
et
al
evolutionari
distanc
sarscov
lineag
b
consider
notion
support
recent
compar
studi
reveal
import
differ
receptor
usag
et
al
raj
et
al
mammalian
virus
cope
host
cell
innat
respons
includ
trigger
activ
type
interferon
ifn
pathway
review
randal
goodbourn
cov
includ
sarscov
appear
evolv
varieti
mechan
block
evad
antivir
respons
review
perlman
netland
zhong
et
al
exampl
postul
sens
dsrna
replic
intermedi
innat
immun
system
inhibit
elabor
virusinduc
membran
structur
cov
rna
synthesi
associ
knoop
et
al
versteeg
et
al
evas
mechan
attribut
protein
function
either
conserv
across
cov
specif
certain
cov
lineag
protein
nonstructur
protein
proteinas
ratia
et
al
et
al
product
sarscov
orf
frieman
et
al
hussain
et
al
kopeckybromberg
et
al
zhou
et
al
describ
prevent
ifn
induct
signal
particular
sarscov
protein
known
inhibit
ifninduc
jakstat
signal
block
nuclear
transloc
phosphoryl
contribut
pathogen
potenti
viru
mous
model
sim
et
al
spite
immun
evas
strategi
treatment
type
ifn
inhibit
cov
replic
vitro
garlinghous
et
al
haagman
et
al
paraga
et
al
taguchi
siddel
zheng
et
al
exampl
protect
type
pneumocyt
sarscov
infect
macaqu
haagman
et
al
clearli
wellcharacter
system
merscov
replic
cell
cultur
invalu
futur
studi
basic
viru
properti
interact
host
includ
innat
immun
respons
therefor
set
character
replic
merscov
differ
cell
line
use
inform
assay
screen
antivir
compound
develop
identifi
cyclosporin
csa
inhibitor
merscov
replic
first
screen
experi
also
establish
compar
sarscov
merscov
replic
sensit
type
ifn
treatment
laboratori
studi
merscov
replic
report
thu
far
cell
varieti
mammalian
host
found
suscept
infect
induc
pronounc
cytopatholog
cell
death
et
al
zaki
et
al
follow
entri
cov
replic
cycl
start
translat
positivesens
rna
genom
replicas
polyprotein
cleav
nsp
gorbalenya
et
al
van
boheemen
et
al
direct
genom
replic
synthesi
subgenom
sg
mrna
requir
express
structur
accessori
protein
investig
merscov
replic
detail
use
vero
cell
analys
viral
rna
synthesi
progeni
releas
singlecycl
infect
experi
hybrid
analysi
accumul
viral
rna
reveal
presenc
genom
rna
seven
sg
transcript
size
close
match
predict
previous
posit
conserv
transcript
regulatori
sequenc
trss
viral
genom
fig
rel
abund
variou
sg
mrna
similar
observ
cov
smallest
speci
encod
nucleocapsid
n
protein
far
abund
transcript
fig
cell
line
viral
mrna
could
readili
detect
h
postinfect
pi
reach
maximum
level
around
h
pi
fig
viral
rna
level
remain
less
constant
h
pi
vero
cell
wherea
amount
isol
cell
declin
due
rapid
develop
cytopatholog
cell
line
h
pi
see
peak
viral
rna
accumul
reach
titr
viru
releas
merscovinfect
vero
cell
increas
steadili
pfu
ml
fig
interestingli
bulk
viral
progeni
releas
significantli
earlier
cell
although
final
titr
h
pi
compar
obtain
vero
cell
despit
rel
larg
evolutionari
distanc
bettercharacter
cov
test
panel
antisera
laboratori
crossreact
merscovinfect
cell
contrast
polyclon
serum
recogn
sarscov
n
protein
data
shown
antisera
variou
sarscov
nsp
snijder
et
al
rais
use
purifi
recombin
protein
antigen
found
crossreact
strongli
fig
addit
rabbit
antisera
rais
synthet
peptid
repres
small
conserv
ctermin
part
sarscov
mhv
strongli
crossreact
merscov
small
appar
immunogen
part
peptid
eg
lyqpp
absolut
conserv
mhv
merscov
fig
conserv
betacoronavirus
data
shown
suggest
antisera
recogn
region
may
use
immunodetect
addit
newli
emerg
cov
subsequ
employ
mab
recogn
dsrna
local
intermedi
viral
rna
synthesi
knoop
et
al
weber
et
al
variou
cell
type
immunolabel
signal
replicas
dsrna
local
perinuclear
region
fig
replic
structur
induc
cov
known
accumul
brockway
et
al
gosert
et
al
knoop
et
al
snijder
et
al
stertz
et
al
ulasli
et
al
next
use
em
investig
ultrastructur
potenti
cytopath
chang
merscov
induc
infect
cell
focus
membran
replic
structur
support
merscov
rna
synthesi
preserv
structur
typic
doublemembran
vesicl
dmv
convolut
membran
cm
found
previous
improv
significantli
use
protocol
includ
cryofix
freez
substitut
knoop
et
al
snijder
et
al
therefor
appli
advanc
preserv
techniqu
includ
newli
develop
protocol
highpressur
freez
hpf
merscovinfect
vero
cell
imag
similarli
prepar
sarscovinfect
vero
cell
includ
comparison
fig
compar
mockinfect
control
cell
fig
differ
degre
distinct
alter
observ
h
pi
cell
contain
rel
small
dmv
cluster
fig
b
black
arrowhead
inset
wherea
other
larg
number
dmv
occupi
extens
area
perinuclear
region
fig
differ
probabl
reflect
differ
stage
infect
progress
diamet
merscovinduc
dmv
rang
nm
compar
measur
previous
sarscovinduc
structur
knoop
et
al
interest
morpholog
differ
previou
studi
sarscovinfect
cell
presenc
dens
inner
dmv
core
attribut
technic
differ
sampl
prepar
term
ultrastructur
preserv
hpf
wide
consid
superior
previous
use
plungefreez
protocol
also
case
sarscov
fig
distantli
relat
equin
arter
viru
knoop
et
al
similar
dens
dmv
core
becam
appar
hpf
employ
although
dmv
core
known
contain
dsrna
implic
ultrastructur
observ
remain
unclear
interestingli
cm
alway
surround
dmv
cluster
observ
cell
appear
advanc
infect
fig
white
arrow
inset
observ
strengthen
notion
dmv
format
preced
develop
cm
postul
previous
sarscov
knoop
et
al
cell
cultur
mani
cov
induc
sever
cytopath
effect
cpe
cell
death
infect
number
cov
also
induc
extens
syncytium
format
due
fusion
activ
viral
spike
protein
neutral
ph
review
belouzard
et
al
merscovinduc
cytopatholog
monitor
light
microscopi
follow
low
moi
inocul
monkey
human
cell
fig
line
previou
observ
vero
cell
develop
clear
cpe
day
pi
detach
day
pi
fig
similar
observ
made
cell
fig
contrast
merscovinfect
vero
cell
display
mild
cpe
start
day
pi
cell
death
complet
day
fig
develop
cpe
cell
strikingli
faster
compar
three
cell
line
follow
extens
syncytium
format
cell
alreadi
detach
around
h
fig
given
low
moi
use
viru
replic
kinet
fig
syncytium
format
partial
infect
cultur
appear
major
factor
cpe
develop
dipeptidyl
express
vero
cell
raj
et
al
express
level
vero
cell
correl
suscept
merscov
data
shown
virusinduc
cpe
vero
cell
use
develop
first
assay
screen
compound
inhibit
merscov
replic
cell
cultur
vero
cell
seed
plate
infect
moi
fig
day
cpe
format
monitor
microscop
cytotox
measur
use
commerci
cell
viabil
assay
moder
cpe
observ
day
day
cell
viabil
uninfect
cell
drop
viru
dose
use
fig
indic
nearcomplet
cell
death
merscovinfect
cell
fig
day
cell
viabil
drop
moi
infect
respect
line
observ
rapid
syncytium
format
cpe
particular
cell
line
fig
day
cpe
complet
viru
dose
use
cell
detach
fig
base
comparison
experi
carri
use
moi
vero
cell
incub
day
respect
measur
cell
viabil
previous
shown
replic
variou
cov
includ
sarscov
inhibit
immunosuppress
drug
csa
de
wild
et
al
pfefferl
et
al
therefor
whilst
test
whether
cpebas
assay
describ
could
use
antivir
screen
method
use
csa
treatment
obtain
first
proof
principl
infect
vero
cell
treat
mm
csa
analys
day
pi
concentr
use
csa
advers
affect
viabil
mockinfect
cell
fig
treatment
mm
complet
inhibit
cpe
left
cell
viabil
unchang
compar
mockinfect
control
cell
inhibitori
effect
csa
confirm
cell
fig
display
reduc
lack
cpe
upon
treatment
mm
csa
respect
type
ifn
inhibit
cov
replic
protect
infect
anim
model
haagman
et
al
taguchi
siddel
therefor
compar
effect
pegyl
ifna
pegifn
treatment
merscov
sarscov
replic
vitro
vero
cell
given
pegifn
h
lowmoi
infect
togeth
inoculum
h
infect
day
pi
cpe
score
microscop
treatment
pegifn
profoundli
inhibit
merscovand
sarscovinduc
cpe
rna
level
dosedepend
manner
fig
day
pi
sarscovinduc
cpe
reduc
time
point
pegifn
addit
use
dose
least
ng
pegifn
ml
fig
wherea
merscovinduc
cpe
alreadi
decreas
use
dose
ng
ml
fig
sarscov
pretreat
ng
pegifn
ml
complet
prevent
cpe
merscov
complet
inhibit
cpe
observ
much
lower
concentr
specif
ng
ml
drug
ad
cell
infect
respect
although
decreas
cpe
also
observ
sarscovinfect
cultur
treat
ng
pegifn
ml
reduct
viral
rna
detect
medium
day
pi
fig
comparison
treatment
merscovinfect
cell
pegifn
dose
complet
block
cpe
reduc
viral
rna
level
medium
depend
time
pegifn
addit
fig
data
reveal
cell
line
merscov
infect
time
sensit
pegifn
treatment
sarscov
infect
differ
may
explain
import
lineagespecif
genet
differ
two
zoonot
betacoronavirus
term
accessori
protein
gene
encod
part
genom
snijder
et
al
van
boheemen
et
al
particular
merscov
encod
homologu
sarscov
protein
report
block
ifninduc
nuclear
transloc
phosphoryl
transcript
factor
nuclear
transloc
essenti
transcript
activ
downstream
antivir
gene
protein
make
sarscov
less
sensit
treatment
type
ifn
frieman
et
al
sim
et
al
ifninduc
transloc
readili
observ
ifntreat
mockinfect
vero
cell
fig
ifntreat
sarscovinfect
cell
fig
f
contrast
merscovinfect
ifntreat
cultur
transloc
detect
fig
g
h
togeth
data
ifn
sensit
fig
observ
highlight
import
differ
sarscov
merscov
term
interact
ifn
signal
pathway
follow
sar
epidem
global
cov
hunt
effort
identifi
wealth
previous
unknown
famili
member
particular
bat
speci
sever
contin
de
groot
et
al
moreov
least
three
four
current
establish
human
cov
postul
origin
zoonot
reservoir
huynh
et
al
pfefferl
et
al
vijgen
et
al
recent
decad
sar
outbreak
merscov
identifi
next
zoonot
cov
appear
highli
pathogen
human
case
confirm
thu
far
fatal
outcom
http
wwwwhointcsrdon
archivediseasecoronavirusinfectionsen
whether
zoonot
cov
caus
transient
epidem
establish
longlast
relationship
human
host
indepth
understand
virushost
interact
requir
develop
effect
countermeasur
studi
defin
sever
basic
import
paramet
merscov
replic
cell
cultur
fig
among
tool
merscov
research
develop
immunoassay
base
crossreact
antisera
rais
betacoronavirus
fig
cpebas
assay
use
screen
antivir
effect
fig
follow
develop
highthroughput
screen
method
antivir
effect
proof
principl
obtain
use
csa
recent
discov
inhibitor
cov
replic
de
wild
et
al
pfefferl
et
al
drug
affect
function
sever
member
cellular
cyclophilin
famili
appear
block
function
interact
viral
protein
one
multipl
cyclophilin
famili
member
nagi
et
al
lowmicromolar
csa
concentr
block
merscovinduc
cpe
vero
cell
mm
respect
observ
previous
cov
de
wild
et
al
pfefferl
et
al
previou
studi
de
wild
et
al
small
fraction
cell
somehow
remain
suscept
merscov
infect
even
high
csa
concentr
thu
viru
replic
could
complet
elimin
may
ultim
lead
develop
csa
resist
cell
cultur
conclus
experi
establish
monitor
merscovinduc
cpe
could
valuabl
rapid
tool
screen
potenti
antivir
activ
exampl
smallmolecul
compound
food
drug
administrationapprov
drug
pegifn
type
ifn
induct
hallmark
earli
innat
immun
respons
counteract
differ
covencod
protein
despit
evas
strategi
ifn
detect
sera
covinfect
mice
human
cameron
et
al
garlinghous
et
al
taguchi
siddel
covinfect
plasmacytoid
dendrit
frieman
et
al
although
contribut
addit
immun
evas
mechan
like
lack
sarscov
homologu
van
boheemen
et
al
may
major
factor
higher
sensit
merscov
pegifn
treatment
observ
studi
recent
work
kindler
et
al
substanti
find
nuclear
transloc
block
merscovinfect
cell
fig
indic
merscov
evolv
altern
strategi
achiev
goal
mhv
shown
rel
insensit
ifn
pretreat
howev
viru
also
block
activ
transloc
instead
inhibit
induct
subset
isg
ifnab
rose
et
al
futur
studi
may
elucid
whether
merscov
evolv
altern
strategi
cope
host
ifn
respons
addit
import
test
whether
merscov
attenu
vivo
result
rel
high
ifn
sensit
pegifn
regist
drug
use
treatment
chronic
hepat
b
c
infect
human
bergman
et
al
sever
cov
includ
sarscov
shown
sensit
type
ifn
treatment
vitro
pegifn
treatment
vivo
haagman
et
al
paraga
et
al
zheng
et
al
studi
establish
rel
high
sensit
merscov
exampl
cynomolgu
macaqu
plasma
level
ng
ml
reach
haagman
et
al
dose
studi
significantli
reduc
merscov
replic
vitro
sensit
merscov
exogen
ifn
suggest
administr
recombin
ifn
merit
evalu
therapeut
intervent
strategi
new
infect
novel
viru
occur
cell
cultur
viru
infect
vero
cell
atcc
cultur
eagl
minim
essenti
medium
emem
lonza
fc
paa
antibiot
cell
grown
dulbecco
modifi
eagl
medium
dmem
lonza
contain
fc
mm
lglutamin
paa
nonessenti
amino
acid
paa
antibiot
vero
cell
cultur
describ
previous
yoshikawa
et
al
antibodi
drug
rabbit
antisera
recogn
sarscov
replicas
subunit
describ
previous
van
hemert
et
al
rabbit
antisera
recogn
sarscov
nucleocapsid
n
protein
mhv
rais
describ
elsewher
snijder
et
al
antigen
fulllength
recombin
sarscov
n
protein
purifi
escherichia
coli
synthet
peptid
repres
ctermin
residu
mhv
respect
detect
alexa
fluor
mous
bd
bioscienc
fitclabel
antimous
igg
use
enhanc
green
fluoresc
viru
infect
detect
use
abovement
sera
alexa
fluor
antirabbit
igg
csa
sigma
dissolv
dmso
mm
stock
store
aliquot
singl
use
uc
peginterferon
pegifn
pegintron
prepar
accord
manufactur
instruct
mg
ml
stock
store
uc
immunofluoresc
microscopi
cell
grown
coverslip
fix
paraformaldehyd
pb
formaldehyd
ethanol
experi
permeabil
triton
process
immunofluoresc
microscopi
describ
previous
first
sampl
maintain
uc
h
medium
slowli
warm
uc
within
h
kept
uc
h
warm
uc
uc
h
rate
left
uc
h
let
sampl
reach
room
temperatur
wash
aceton
sampl
gradual
infiltr
epoxi
resin
polymer
uc
sampl
cut
thin
section
nm
counterstain
uranyl
acet
lead
citrat
imag
perform
fei
twin
electron
microscop
oper
kv
equip
eagl
cool
slowscan
chargecoupl
devic
camera
fei
compani
imag
acquir
use
bin
mode
intracellular
viral
rna
analysi
isol
intracellular
viral
rna
carri
describ
previous
van
kasteren
et
al
dri
gel
viral
mrna
detect
hybrid
plabel
oligonucleotid
probe
complementari
end
merscov
mrna
equal
load
verifi
second
hybrid
use
plabel
oligonucleotid
probe
recogn
rrna
van
hemert
et
al
imagequ
tl
softwar
ge
healthcar
use
quantif
realtim
revers
transcriptionpcr
rtpcr
rna
ml
cultur
medium
covinfect
cell
isol
magnapur
lc
total
nucleic
acid
isol
kit
roch
elut
ml
rtpcr
condit
quantifi
merscov
sarscov
rna
amplif
paramet
describ
previous
kuiken
et
al
raj
et
al
dilut
viral
rna
isol
merscov
sarscov
viru
stock
known
viru
titr
use
produc
standard
curv
develop
screen
assay
antivir
compound
vero
cell
seed
plate
densiti
cell
per
well
respect
overnight
growth
cell
infect
moi
day
incub
differ
cell
viabil
caus
virusinduc
cpe
compoundspecif
side
effect
analys
use
celltit
aq
ueou
nonradioact
cell
prolifer
assay
promega
accord
manufactur
instruct
absorb
nm
measur
use
berthold
mithra
lb
plate
reader
infect
cell
given
csa
dmso
solvent
control
prior
infect
moi
cytotox
effect
caus
csa
treatment
alon
monitor
parallel
plate
contain
mockinfect
cell
ifn
sensit
transloc
experi
one
day
prior
infect
vero
cell
plate
densiti
cell
per
well
plate
format
h
pi
cell
incub
ng
pegifn
ml
ml
h
well
wash
pb
infect
merscov
sarscov
tcid
per
ml
medium
cultur
receiv
treatment
infect
presenc
indic
concentr
pegifn
h
ml
medium
ad
cultur
cultur
ml
medium
ad
untreat
cultur
h
pi
receiv
ml
medium
supplement
pegifn
reach
final
concentr
ng
pegifn
ml
h
pi
rna
isol
ml
cellcultur
supernat
quantifi
use
virusspecif
realtim
rtpcr
assay
see
h
pi
cpe
also
score
microscop
either
none
mild
moder
sever
complet
nuclear
transloc
experi
vero
cell
infect
merscov
sarscov
moi
h
pi
cell
treat
ng
pegifn
ml
min
fix
formaldehyd
ethanol
subsequ
stain
presenc
viral
antigen
transloc
